InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

IRADIMED CORP

IRMD Clue Score75
United States Fiscal year ends December CIK 0001325618
$87.45 +1.83% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $87.45 +144.07% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue32.5Operating income10.9Net income7.2EPS, diluted0.60Fiscal year 2017Revenue23.1 −29.0%Operating income1.3Net income0.5 −93.1%EPS, diluted0.04 −93.3%Fiscal year 2018Revenue30.4 +31.9%Operating income6.0Net income6.3 +1,161.3%EPS, diluted0.52 +1,200.0%Fiscal year 2019Revenue38.5 +26.5%Operating income8.6Net income9.6 +52.8%EPS, diluted0.78 +50.0%Fiscal year 2020Revenue31.7 −17.7%Operating income−0.8Net income1.4 −85.8%EPS, diluted0.11 −85.9%Fiscal year 2021Revenue41.8 +31.8%Operating income9.8Net income9.3 +581.2%EPS, diluted0.74 +572.7%Fiscal year 2022Revenue53.3 +27.5%Operating income15.6Net income12.8 +37.6%EPS, diluted1.02 +37.8%Fiscal year 2023Revenue65.6 +23.0%Operating income20.0Net income17.2 +34.0%EPS, diluted1.35 +32.4%Fiscal year 2024Revenue73.2 +11.7%Operating income22.0Net income19.2 +11.9%EPS, diluted1.50 +11.1%Fiscal year 2025Revenue83.8 +14.4%Operating income26.1Net income22.5 +16.9%EPS, diluted1.75 +16.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 32.5 23.1 30.4 38.5 31.7 41.8 53.3 65.6 73.2 83.8
Growth −29.0% +31.9% +26.5% −17.7% +31.8% +27.5% +23.0% +11.7% +14.4%
Operating income 10.9 1.3 6.0 8.6 −0.8 9.8 15.6 20.0 22.0 26.1
Net income 7.2 0.5 6.3 9.6 1.4 9.3 12.8 17.2 19.2 22.5
Growth −93.1% +1,161.3% +52.8% −85.8% +581.2% +37.6% +34.0% +11.9% +16.9%
EPS, diluted 0.60 0.04 0.52 0.78 0.11 0.74 1.02 1.35 1.50 1.75
Growth −93.3% +1,200.0% +50.0% −85.9% +572.7% +37.8% +32.4% +11.1% +16.7%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin81.1%Operating margin33.6%Net margin22.2%Free cash flow margin26.5%Fiscal year 2017Gross margin75.9%Operating margin5.6%Net margin2.2%Free cash flow margin11.4%Fiscal year 2018Gross margin76.3%Operating margin19.7%Net margin20.7%Free cash flow margin23.5%Fiscal year 2019Gross margin77.1%Operating margin22.5%Net margin25.0%Free cash flow margin25.6%Fiscal year 2020Gross margin74.3%Operating margin−2.4%Net margin4.3%Free cash flow margin16.9%Fiscal year 2021Gross margin76.6%Operating margin23.5%Net margin22.3%Free cash flow margin25.8%Fiscal year 2022Gross margin77.4%Operating margin29.3%Net margin24.1%Free cash flow margin17.3%Fiscal year 2023Gross margin76.5%Operating margin30.6%Net margin26.2%Free cash flow margin9.2%Fiscal year 2024Gross margin76.9%Operating margin30.0%Net margin26.3%Free cash flow margin24.1%Fiscal year 2025Gross margin76.7%Operating margin31.2%Net margin26.8%Free cash flow margin20.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 81.1% 75.9% 76.3% 77.1% 74.3% 76.6% 77.4% 76.5% 76.9% 76.7%
Operating margin 33.6% 5.6% 19.7% 22.5% −2.4% 23.5% 29.3% 30.6% 30.0% 31.2%
Net margin 22.2% 2.2% 20.7% 25.0% 4.3% 22.3% 24.1% 26.2% 26.3% 26.8%
Free cash flow margin 26.5% 11.4% 23.5% 25.6% 16.9% 25.8% 17.3% 9.2% 24.1% 20.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow9.4Capital expenditure−0.8Free cash flow8.6Buybacks−10.0Fiscal year 2017Operating cash flow3.4Capital expenditure−0.8Free cash flow2.6 −69.4%Buybacks−1.8Fiscal year 2018Operating cash flow7.4Capital expenditure−0.2Free cash flow7.1 +170.7%Fiscal year 2019Operating cash flow10.2Capital expenditure−0.4Free cash flow9.9 +38.0%Fiscal year 2020Operating cash flow5.8Capital expenditure−0.4Free cash flow5.4 −45.5%Fiscal year 2021Operating cash flow11.3Capital expenditure−0.5Free cash flow10.8 +100.5%Fiscal year 2022Operating cash flow10.0Capital expenditure−0.8Free cash flow9.2 −14.4%Dividends paid−12.6Fiscal year 2023Operating cash flow13.5Capital expenditure−7.4Free cash flow6.0 −34.7%Dividends paid−13.2Fiscal year 2024Operating cash flow25.6Capital expenditure−8.0Free cash flow17.6 +192.5%Dividends paid−13.7Fiscal year 2025Operating cash flow24.9Capital expenditure−7.8Free cash flow17.2 −2.5%Dividends paid−15.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 9.4 3.4 7.4 10.2 5.8 11.3 10.0 13.5 25.6 24.9
Capital expenditure −0.8 −0.8 −0.2 −0.4 −0.4 −0.5 −0.8 −7.4 −8.0 −7.8
Free cash flow 8.6 2.6 7.1 9.9 5.4 10.8 9.2 6.0 17.6 17.2
Growth −69.4% +170.7% +38.0% −45.5% +100.5% −14.4% −34.7% +192.5% −2.5%
Buybacks −10.0 −1.8 n/a n/a n/a n/a n/a n/a n/a n/a
Dividends paid n/a n/a n/a n/a n/a n/a −12.6 −13.2 −13.7 −15.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash17.7Shareholders’ equity31.9Fiscal year 2017Cash18.2Shareholders’ equity32.9Fiscal year 2018Cash28.0Shareholders’ equity41.9Fiscal year 2019Cash43.5Shareholders’ equity55.5Fiscal year 2020Cash50.1Shareholders’ equity61.4Fiscal year 2021Cash62.0Shareholders’ equity72.2Fiscal year 2022Cash58.0Shareholders’ equity73.7Fiscal year 2023Cash49.8Shareholders’ equity71.4Fiscal year 2024Cash52.2Shareholders’ equity86.8Fiscal year 2025Cash51.2Shareholders’ equity94.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 17.7 18.2 28.0 43.5 50.1 62.0 58.0 49.8 52.2 51.2
Shareholders’ equity 31.9 32.9 41.9 55.5 61.4 72.2 73.7 71.4 86.8 94.6

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
32.5 23.1 30.4 38.5 31.7 41.8 53.3 65.6 73.2 83.8
Growth −29.0% +31.9% +26.5% −17.7% +31.8% +27.5% +23.0% +11.7% +14.4%
6.2 5.6 7.2 8.8 8.1 9.8 12.0 15.4 16.9 19.5
26.3 17.5 23.2 29.7 23.6 32.0 41.3 50.2 56.4 64.3
Growth −33.5% +32.6% +27.9% −20.6% +36.0% +28.8% +21.5% +12.3% +14.2%
1.3 1.7 1.5 1.4 1.9 1.9 2.3 2.9 2.8 3.0
8.8 9.0 8.7 10.5 12.3 9.8 10.7 15.1 15.9 17.8
10.9 1.3 6.0 8.6 −0.8 9.8 15.6 20.0 22.0 26.1
Growth −88.2% +367.2% +44.0% −108.7% +59.2% +28.2% +9.6% +19.0%
11.0 1.4 6.2 9.0 −0.6 9.8 16.2 21.7 24.3 28.4
3.7 0.9 −0.1 −0.6 −2.0 0.5 3.4 4.5 5.0 5.9
7.2 0.5 6.3 9.6 1.4 9.3 12.8 17.2 19.2 22.5
Growth −93.1% +1,161.3% +52.8% −85.8% +581.2% +37.6% +34.0% +11.9% +16.9%
Per share
0.67 0.05 0.59 0.85 0.11 0.76 1.02 1.36 1.52 1.77
0.60 0.04 0.52 0.78 0.11 0.74 1.02 1.35 1.50 1.75
Growth −93.3% +1,200.0% +50.0% −85.9% +572.7% +37.8% +32.4% +11.1% +16.7%
10.8 10.6 10.8 11.3 12.1 12.3 12.6 12.6 12.7 12.7
12.0 11.7 12.1 12.3 12.4 12.6 12.6 12.7 12.8 12.9
Growth −2.2% +3.3% +1.4% +1.3% +1.2% +0.4% +0.7% +0.5% +0.5%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 21.5% a year over five years, and earnings per share grew 73.9% a year.
  • The diluted share count rose 3.3% in five years, which is dilution.
  • Operating margin is up 33.6 points on five years ago, at 31.2%.
  • Profitable in every one of the 10 years on file.